← Open Payments lookup

GLEN ORDINARIO: Open Payments

NPI 1639465487 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 35 payments from 14 companies in 2025. Trend: 2023 $973 · 2024 $1,110 · 2025 $781

Food & beverage: $781
CompanyPaymentsAmount
GlaxoSmithKline, LLC.6$155
Amgen Inc.6$126
Novo Nordisk Inc3$75
ANI Pharmaceuticals, Inc.2$68
Boehringer Ingelheim Pharmaceuticals, Inc.4$67
AstraZeneca Pharmaceuticals LP3$63
Otsuka America Pharmaceutical, Inc.3$59
Calliditas Therapeutics US Inc.2$47
Lilly USA, LLC1$28
Novartis Pharmaceuticals Corporation1$25

Products named: BENLYSTA, JARDIANCE, KRYSTEXXA, Ozempic, PURIFIED CORTROPHIN GEL, LOKELMA, JYNARQUE, TAVNEOS.

Industry payments across CA — which companies pay providers there.